Effectiveness of Autologous Hematopoietic Stem Cell Transplantation versus Alemtuzumab and Ocrelizumab in Relapsing Multiple Sclerosis: A Single Center Cohort Study.

The ARR was significantly lower among those who had AHSCT compared with OCR, but the difference between the 2 groups in the cumulative proportion of patients free of relapses (91.3% vs 80.7%) did not reach statistical significance, although in sensitivity analyses, the transplant was shown to exert a statistically significant greater effect also on the time to new relapses (Table S5).

also in 111,027 other papers